Supplementary Table 1 - Engineered mesoporous silica reduces long-term blood glucose and HbA1c, and improve metabolic parameters in prediabetics

T Bengtsson is supported by the Vetenskapsradet Medicin (VR-M) from the Swedish Research Council. T Bengtsson owns stock in the following pharmaceutical companies: Sigrid Therapeutics AB, Atrogi AB and Glucox Biotechnology AB. The following authors are or were employed by Sigrid Therapeutics AB: J Baek, G Robert-Nicoud, C. Herrera Hidalgo, ML Borg, MN Iqbal, M Lindgren, ER Waara, A Uddén. T Bengtsson is one of the inventors of the patent family WO2014072363A1. T Bengtsson and MN Iqbal are inventors of the patent family WO2019166656A1.